Skip to content

Author

Sudesh Prajapathi

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Trimetazidine in Heart Failure: From Metabolic Modulation to Clinical Outcomes—A Narrative Review

Heart Failure (HF) remains a leading cause of morbidity and mortality worldwide despite major advances in guideline-directed medical therapy. Metabolic remodeling with impaired myocardial energy utilization has emerged as an important therapeutic target in HF. Trimetazidine, a metabolic modulator that partially inhibit...

Akshyaya Pradhan, Sudesh Prajapathi, K. Mahajan et al. · 0 citations
Open access Oct 2026

Early efficacy of oral lipid lowering therapy in achieving LDL-C targets following acute coronary syndrome: A real-world observational study

Low LDL-C target attainment following ACS remains suboptimal despite high-intensity statin therapy, highlighting the need for earlier and more intensive lipid-lowering strategies in high-risk Indian patients.

A. Gautam, Sudesh Prajapathi, Abhishek Singh et al. · 1 citation
Open access Sep 2026

Systemic Immune–Inflammation Index Predicting Acute Cardiovascular Outcomes

Background/Objectives: Acute coronary syndrome (ACS) and acute decompensated heart failure (ADHF) are associated with substantial short-term morbidity and mortality. The systemic immune–inflammation index (SII) reflects inflammatory and thrombotic activity, but its prognostic value beyond conventional biomarkers and cl...

Y. Khan, Sudesh Prajapathi, Mahadev Meena et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.